Guava Technologies

company

About

Guava Technologies is a privately-held biotechnology and medical device company that develops & manufactures unique flow cytometry systems.

  • 51 - 100

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$10M
Industries
Biotechnology,Health Diagnostics,Medical Device
Founded date
Jan 1, 1998
Number Of Employee
51 - 100
Operating Status
Active

Guava Technologies, Inc. develops, designs, and manufactures biotechnology and medical devices. Its products include HIV/AIDS monitoring, viacount cell counting and viability assay, antibody quantification assay, apoptosis assay suite, cell cycle assay, cytotoxicity assay, cell proliferation assay, and benchtop cell analysis systems. Guava Technologies also offers flow cytometry systems for cell biology research, drug discovery and development, and HIV/AIDS monitoring. It serves life science research, drug discovery and development, cell biology research, core flow cytometry, and clinical diagnostics markets. The company's products are used in cell counting/viability, antibody quantification, cell cycle and proliferation, cytotoxicity, and apoptosis applications. Guava Technologies, Inc. was founded in 1998 and is headquartered in Hayward, California. As of February 20, 2009, Guava Technologies, Inc. operates as a subsidiary of Millipore Corp.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Guava Technologies has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Dec 21, 2005 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 21, 2005 Debt Financing $10M 1 Hercules Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Guava Technologies is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Debt Financing